GATA2 and posterior cortical atrophy: In line with these observations, we also found that PCa patients with higher GATA2 expression levels were associated with elevated risk of biochemical recurrence and metastasis (Fig. 1g, h), consistent with previous notion that GATA2 upregulation or increased transcriptional activity is positively associated with poor prognosis of PCa patients [20, 62, 63].